Edges in Network
| Network | GSE16391_egf1520 - GSE16391 - SiGN-BN HC+Bootstrap |
| Network Description | GGI: a potential predictor of relapse for endocrine-treated breast cancer patients in the BIG 1-98 trial |
| Node | MYL6B |
| Upstream (Parents) |
|---|
| (<<) CASP1 → MYL6B |
| (<<) CDK4 → MYL6B |
| (<<) CYP1A2 → MYL6B |
| (<<) FNBP1 → MYL6B |
| (<<) FUT1 → MYL6B |
| (<<) GALK1 → MYL6B |
| (<<) GNRH2 → MYL6B |
| (<<) HDAC5 → MYL6B |
| (<<) ITGA6 → MYL6B |
| (<<) NAB2 → MYL6B |
| (<<) PALM → MYL6B |
| (<<) PDGFB → MYL6B |
| (<<) PTMS → MYL6B |
| (<<) UAP1 → MYL6B |
| Downstream (Children) |
|---|
| MYL6B → CYP1A1 (>>) |
| MYL6B → DOK7 (>>) |
| MYL6B → ELF1 (>>) |
| MYL6B → ENO2 (>>) |
| MYL6B → ERRFI1 (>>) |
| MYL6B → GPR78 (>>) |
| MYL6B → IL27 (>>) |
| MYL6B → KRAS (>>) |
| MYL6B → MBOAT2 (>>) |
| MYL6B → MTSS1 (>>) |
| MYL6B → RHOT1 (>>) |
